Clinical Trial Update: Y-90 SIRT for Unresectable HCC Larger Than 7cm [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating yttrium-90 selective internal radiation therapy for unresectable hepatocellular carcinoma larger than 7 cm is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Y-90 SIRT (yttrium-90 selective internal radiation therapy)

Snippet

Sponsor: Second Affiliated Hospital of Guangzhou Medical University | Conditions: Hepatocellular Carcinoma Non-Resectable | Phase 2 | Status: RECRUITING